Literature DB >> 26863997

Factors Associated With Health-Related Quality of Life in Children With Duchenne Muscular Dystrophy.

Yi Wei1, Kathy Nixon Speechley2, Guangyong Zou3, Craig Campbell4.   

Abstract

This study investigated clinical and family characteristics associated with health-related quality of life in children with Duchenne muscular dystrophy. Families of 176 boys with Duchenne muscular dystrophy were identified and mailed questionnaires via the Canadian Neuromuscular Disease Registry. Multiple linear regressions analyses were used to examine the relationship between clinical and family characteristics and child-self and parent-proxy reported health-related quality of life. Greater fatigue and use of wheelchairs were consistently associated with worse health-related quality of life independent of other factors. Higher household income and parent having a postsecondary degree were associated with better health-related quality of life in some of the measures. A greater clinical focus on and efforts to reduce fatigue could lead to improvement of health-related quality of life in the Duchenne muscular dystrophy population. This study also sets the ground for longitudinal studies where changes in health-related quality of life can be monitored over time.
© The Author(s) 2016.

Entities:  

Keywords:  Duchenne muscular dystrophy; fatigue; health-related quality of life; neuromuscular; registry

Mesh:

Year:  2016        PMID: 26863997     DOI: 10.1177/0883073815627879

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  8 in total

1.  Predictors of Health-Related Quality of Life in boys with Duchenne muscular dystrophy from six European countries.

Authors:  Christiane Otto; Birgit F Steffensen; Ann-Lisbeth Højberg; Claus Barkmann; Jes Rahbek; Ulrike Ravens-Sieberer; Annette Mahoney; Julia Vry; Kathrin Gramsch; Rachel Thompson; Sunil Rodger; Kate Bushby; Hanns Lochmüller; Janbernd Kirschner
Journal:  J Neurol       Date:  2017-02-07       Impact factor: 4.849

Review 2.  Measuring quality of life in children with spinal muscular atrophy: a systematic literature review.

Authors:  Shalvaree Vaidya; Stefan Boes
Journal:  Qual Life Res       Date:  2018-07-24       Impact factor: 4.147

3.  Development of a New Quality of Life Measure for Duchenne Muscular Dystrophy Using Mixed Methods: The DMD-QoL.

Authors:  Philip A Powell; Jill Carlton; Donna Rowen; Fleur Chandler; Michela Guglieri; John E Brazier
Journal:  Neurology       Date:  2021-03-30       Impact factor: 9.910

4.  Dynamic arm study: quantitative description of upper extremity function and activity of boys and men with duchenne muscular dystrophy.

Authors:  Mariska M H P Janssen; Jaap Harlaar; Bart Koopman; Imelda J M de Groot
Journal:  J Neuroeng Rehabil       Date:  2017-05-26       Impact factor: 4.262

5.  Fatigue in adults with spinal muscular atrophy under treatment with nusinersen.

Authors:  K Kizina; B Stolte; A Totzeck; S Bolz; M Schlag; C Ose; O von Velsen; C Kleinschnitz; Tim Hagenacker
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

6.  Producing a preference-based quality of life measure for people with Duchenne muscular dystrophy: a mixed-methods study protocol.

Authors:  Philip A Powell; Jill Carlton; Donna Rowen; John E Brazier
Journal:  BMJ Open       Date:  2019-03-09       Impact factor: 2.692

7.  Objective and subjective measures of sleep in men with Muscular Dystrophy.

Authors:  Christopher I Morse; Gladys Onambele-Pearson; Bryn Edwards; Sze Choong Wong; Matthew F Jacques
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

8.  The Canadian Neuromuscular Disease Registry: Connecting patients to national and international research opportunities.

Authors:  Yi Wei; Anna McCormick; Alex MacKenzie; Erin O'Ferrall; Shannon Venance; Jean K Mah; Kathryn Selby; Hugh J McMillan; Garth Smith; Maryam Oskoui; Gillian Hogan; Laura McAdam; Gracia Mabaya; Victoria Hodgkinson; Josh Lounsberry; Lawrence Korngut; Craig Campbell
Journal:  Paediatr Child Health       Date:  2017-12-08       Impact factor: 2.253

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.